Literature DB >> 28493273

Use of amphetamine-type stimulants in the Islamic Republic of Iran, 2004-2015: a review.

Behrang Shadloo1, Masoumeh Amin-Esmaeili1, Minoo Haft-Baradaran2, Alireza Noroozi3, Reza Ghorban-Jahromi1, Afarin Rahimi-Movaghar1.   

Abstract

Amphetamine-type stimulants (ATS) are the second most commonly used illicit drugs in the world, after cannabis. The production of ATS has increased worldwide, including in the Middle East. This review aims to assess ATS use in the Islamic Republic of Iran. PubMed, Scientific Information Database (a national database) and Iranian Center for Addiction Studies were searched. The review included studies on the general population, university and high school students, other specific populations, and drug users. The result show that self-reported methamphetamine and ecstasy use in 2016 was < 1% in the general population and university and high-school students, but the prevalence was higher in certain groups. There has also been an increase in the proportion of ATS users among clients of drug treatment centres. The findings highlight the need for high quality epidemiological studies and closer monitoring of stimulant use in different populations.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28493273     DOI: 10.26719/2017.23.3.245

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  7 in total

1.  Evidence for an increase in cannabis use in Iran - A systematic review and trend analysis.

Authors:  Yasna Rostam-Abadi; Jaleh Gholami; Masoumeh Amin-Esmaeili; Shahab Baheshmat; Marziyeh Hamzehzadeh; Hossein Rafiemanesh; Morteza Nasserbakht; Leila Ghalichi; Anousheh Safarcherati; Farhad Taremian; Ramin Mojtabai; Afarin Rahimi-Movaghar
Journal:  PLoS One       Date:  2021-08-30       Impact factor: 3.240

2.  No evidence of subgroups found in amphetamine consumers in Iran.

Authors:  Atireza Bananej; Sabine Völkl-Kernstock; Otto Lesch; Henriette Walter; Katrin Skala
Journal:  Neuropsychiatr       Date:  2018-03-07

3.  Adding extended-release methylphenidate to psychological intervention for treatment of methamphetamine dependence: A double-blind randomized controlled trial.

Authors:  Alireza Noroozi; Seyed Abbas Motevalian; Mohammad-Reza Zarrindast; Javad Alaghband-Rad; Shahin Akhondzadeh
Journal:  Med J Islam Repub Iran       Date:  2020-10-14

4.  Regional Homogeneity Abnormalities and Its Correlation With Impulsivity in Male Abstinent Methamphetamine Dependent Individuals.

Authors:  Yanan Zhou; Qianjin Wang; Honghong Ren; Xuyi Wang; Yanhui Liao; Zhi Yang; Yuzhu Hao; Yunfei Wang; Manyun Li; Yuejiao Ma; Qiuxia Wu; Yingying Wang; Dong Yang; Jiang Xin; Winson Fu Zun Yang; Long Wang; Tieqiao Liu
Journal:  Front Mol Neurosci       Date:  2022-01-20       Impact factor: 5.639

5.  Profile of drug users in the residential treatment centers of Tehran, Iran.

Authors:  Hossein Akbari; Mohsen Roshanpajouh; Keramat Nourijelyani; Mohammad-Ali Mansournia; Afarin Rahimi-Movaghar; Kamran Yazdani
Journal:  Health Promot Perspect       Date:  2019-08-06

Review 6.  Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis.

Authors:  Yasna Rostam-Abadi; Hossein Rafiemanesh; Jaleh Gholami; Behrang Shadloo; Masoumeh Amin-Esmaeili; Afarin Rahimi-Movaghar
Journal:  Harm Reduct J       Date:  2020-10-21

7.  Prevalence of Substance Use among Psychotic Patients and Determining Its Strongest Predictor.

Authors:  Seyedeh Bentolhoda Mousavi; Peter Higgs; Negar Piri; Ensieh Sadri; Matina Pourghasem; Sanaz Jafarzadeh Fakhari; Mehdi Noroozi; Mojtaba Miladinia; Elaheh Ahounbar; Asaad Sharhani
Journal:  Iran J Psychiatry       Date:  2021-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.